echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > FDA requires Pfizer/BioNTech and Moderna new crown vaccines to add label warnings

    FDA requires Pfizer/BioNTech and Moderna new crown vaccines to add label warnings

    • Last Update: 2021-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationFan Dongdong

    Many new coronavirus vaccines are currently facing development delays and safety and supply issues, but the mRNA vaccines from Pfizer/BioNTech and Moderna have become the leader of similar products relatively unfettered


    However, on June 24, according to foreign media reports, American experts concluded that there is a "possible link" between rare cases of cardiac inflammation and mRNA vaccines, which has brought certain harm to Pfizer/BioNTech and Moderna's vaccine injections.


    The FDA said it will take swift action to require these companies to add label warnings stating that young people and teenagers are susceptible to side effects


    Although the Centers for Disease Control and Prevention (CDC) concluded that the benefits of the vaccine clearly outweigh the risks, the ruling may force those with fear to favor adenovirus vaccines provided by Johnson & Johnson and AstraZeneca


    The latest ruling is aimed at young people (mostly men), who developed myocarditis (cardiac inflammation) or pericarditis (cardiac membrane inflammation) mainly after the second dose of mRNA vaccine


    CDC's vaccine safety data link shows that among people aged 12 to 39, the incidence of heart inflammation is 12.


    Pfizer said in a statement: "Cardiac inflammation is an extremely rare side effect, and only a very small number of people will experience it after vaccination.


    Moderna issued a similar statement, adding that the company will work closely with the FDA and other regulatory agencies to take appropriate next steps


    Reference source: Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.